The great work carried out at the Technological Innovation Department of VIVEbiotech and lead by Andrés Lamsfus-Calle and Marie Fertin describes the development and characterization of a platform for the generation of stable inducible producer lines.
Currently, this work is still ongoing at our Process Development Department, with the objective of demonstrating their adaptability to VIVEbiotech’s well-stablished plug-and-play manufacturing platform.
We strongly believe that this publication reinforces our development capabilities and consolidates VIVEbiotech as a recognized player in the advanced therapies market.
Huge congratulations to all the authors, especially to the first author Ane Arrasate who was at the ESGCT´s annual congress in Rome presenting a poster that compiles the work collected in this article.
The open-access piece can be read here: https://www.mdpi.com/2227-9059/12/10/2265